Human Milk Oligosaccharides (HMO) Market Regional Analysis & Forecast

The global Human Milk Oligosaccharides Market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period.

The global HMO market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value sales during the forecast period. With the rise in number of infants across the globe, the demand and preference for HMO-based infant formula along with the trend of adopting healthy lifestyle by consuming functional food and beverages has significantly boosted the utilization of HMO in manufacturing.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220134357

Asia Pacific dominated the HMO market, with a value of USD 92.6 million in 2021; it is projected to reach USD 321.8 million by 2027, at a CAGR of 23.2% during the forecast period.

Asia Pacific consisting of countries like China, India, Japan, Australia New Zealand and Others is found to dominate the HMO market with presence of large consumer base for HMO derivative products. The region is densely populated with countries like China and India, witnessing a rapid rise in infant population every year. This tendency of population rising is influencing the infant formula market where HMO is used as a vital ingredient for formulating infant foods and other supplements.

New Zealand is one of the major exporters of infant formulas to China, which generates high revenue for the country; hence, the market of HMO-based infant formulas in New Zealand is expected to witness substantial growth during the forecast period. Japan is expected to witness gradual growth in the HMO market, due to the decline in birth rates in recent years. According to an article published by the World Economic Forum in January 2022, the number of births recorded in Japan in 2020 stood at 840,832, which is 2.8% lower than in 2019 and the lowest since 1899.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=220134357

The key players in this market include DSM (Netherlands), BASF SE (Germany), Chr. Hansen Holding A/S (Denmark), DUPONT ( US), and Royal FrieslandCampina N.V. (Netherlands).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.